Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 5, 2010, Pages 1132-1140

  Muhi, Ali ^a   Ichikawa, Tomoaki ^a   Motosugi, Utaroh ^a   Sou, Hironobu ^a   Nakajima, Hiroto ^a   Sano, Katsuhiro ^a   Kitamura, Takatoshi ^a   Faima, Zareen ^a   Fukushima, Kimiyo ^a   Araki, Tsutomu ^a   Iino, Hiroshi ^a   Mori, Yoshiyuki ^a   Fujii, Hideki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

colorectal hepatic metastasis; contrast enhanced CT; contrast enhanced ultrasound; DWI; SPIO MRI

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS;

COLORECTAL NEOPLASMS; CONTRAST MEDIA; DEXTRANS; DIFFUSION MAGNETIC RESONANCE IMAGING; FERRIC COMPOUNDS; HUMANS; IRON; LIVER NEOPLASMS; MAGNETITE NANOPARTICLES; OXIDES; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 78349290825     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22360     Document Type: Article

References (27)

1. Cavallari A, Vivarelli M, Bellusci R, et al. Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology 2003; 50: 2067-2071.
2. Penna C, Nordlinger B., Colorectal metastasis (liver and lung). Surg Clin North Am 2002; 82: 1075-1090 xi.x-1090 xi.
3. Taschieri AM, Elli M, Vignati GA, et al. Repeated liver resection for recurrent metastases from colorectal cancer. Hepatogastroenterology 2003; 50: 472-474.
4. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H., Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007; 33: 318-325.
5. Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M., Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007; 42: 643-651.
6. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008; 51 (Suppl 1): 61-69.
7. Hatanaka K, Kudo M, Minami Y, Maekawa K., Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75 (Suppl 1): 42-47.
8. Luo W, Numata K, Kondo M, et al. Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index. J Ultrasound Med 2009; 28: 439-448.
9. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M,. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609.
10. Sugimoto K, Shiraishi J, Moriyasu F, Saito K, Doi K., Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis. Acad Radiol 2009; 16: 798-809.
11. Nakano H, Ishida Y, Hatakeyama T, et al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 2008; 14: 3207-3211.
12. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-792.
13. Del Frate C, Bazzocchi M, Mortele KJ, et al. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 2002; 225: 766-772.
14. Del Frate C, Zuiani C, Londero V, et al. Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases. AJR Am J Roentgenol 2003; 180: 1339-1346.
15. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol 1990; 155: 763-770.
16. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B., Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471-478.
17. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005; 237: 170-180.
18. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-130.
19. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007; 80: 524-531.
20. Bruegel M, Gaa J, Waldt S, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 2008; 191: 1421-1429.
21. Bruegel M, Rummeny EJ., Hepatic metastases: use of diffusion-weighted echo-planar imaging. Abdom Imaging 2010; 35: 454-461.
22. Lyng H, Haraldseth O, Rofstad EK., Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000; 43: 828-836.
23. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc 2009; 107: 403-405.
24. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Nurs Ethics 2002; 9: 105-109.
25. Ichikawa T, Erturk SM, Araki T., Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. Eur J Radiol 2006; 58: 165-176.
26. Kumano S, Murakami T, Kim T, et al. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. AJR Am J Roentgenol 2003; 181: 1335-1339.
27. Onishi H, Murakami T, Kim T, et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006; 239: 131-138.